Q3 2026 13F filing
Updated 6 days ago172 disclosed positions worth $994.2M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MODERNA INC | $77M | 400.0K | 7.75% | — |
| 2 | C BRISTOL-MYERS SQUIBB CO | $61.9M | 992.5K | 6.23% | — |
| 3 | K KODIAK SCIENCES INC | $50.5M | 533.1K | 5.08% | — |
| 4 | S SPDR SERIES TRUST | $47.3M | 300.0K | 4.76% | — |
| 5 | P PRAXIS PRECISION MEDICINES I | $29.1M | 99.8K | 2.92% | — |
| 6 | A ABIVAX SA | $28.4M | 285.9K | 2.86% | — |
| 7 | I DISC MEDICINE INC | $25.5M | 389.1K | 2.56% | — |
| 8 | P VAXCYTE INC | $22.8M | 400.5K | 2.29% | — |
| 9 | R ARCUS BIOSCIENCES INC | $19M | 734.6K | 1.91% | — |
| 10 | I INCYTE CORP | $18.2M | 150.0K | 1.83% | — |
| 11 | A ACADIA PHARMACEUTICALS INC | $17.1M | 850.0K | 1.72% | — |
| 12 | P VAXCYTE INC | $17.1M | 300.0K | 1.72% | — |
| 13 | C CELLDEX THERAPEUTICS INC NEW | $16.8M | 518.5K | 1.69% | — |
| 14 | A AMYLYX PHARMACEUTICALS INC | $16.3M | 561.5K | 1.64% | — |
| 15 | P PHARVARIS N V | $15.9M | 502.4K | 1.60% | — |
| 16 | K KYMERA THERAPEUTICS INC | $14.9M | 133.1K | 1.50% | — |
| 17 | K KODIAK SCIENCES INC | $14.2M | 149.6K | 1.43% | — |
| 18 | I DISC MEDICINE INC | $13.1M | 200.0K | 1.32% | — |
| 19 | V VERA THERAPEUTICS INC | $12.9M | 400.0K | 1.30% | — |
| 20 | A ALTO NEUROSCIENCE INC | $12.3M | 482.3K | 1.24% | — |
| 21 | C COGENT BIOSCIENCES INC | $11.9M | 370.1K | 1.19% | — |
| 22 | S SUMMIT THERAPEUTICS INC | $11M | 650.0K | 1.11% | — |
| 23 | A ANI PHARMACEUTICALS INC | $10.8M | 149.1K | 1.09% | — |
| 24 | E ENLIVEN THERAPEUTICS INC | $10.6M | 232.1K | 1.07% | — |
| 25 | R RAPPORT THERAPEUTICS INC | $10.6M | 316.4K | 1.07% | — |
| 26 | A ABIVAX SA | $9.9M | 100.0K | 1.00% | — |
| 27 | N NEWAMSTERDAM PHARMA COMPANY | $9.7M | 400.0K | 0.98% | — |
| 28 | N NEWAMSTERDAM PHARMA COMPANY | $9.7M | 400.0K | 0.98% | — |
| 29 | M MAZE THERAPEUTICS INC | $8.2M | 301.4K | 0.82% | — |
| 30 | C CELLDEX THERAPEUTICS INC NEW | $8.2M | 251.5K | 0.82% | — |
| 31 | C CONTINEUM THERAPEUTICS INC | $8M | 594.7K | 0.80% | — |
| 32 | ? N/A CUE BIOPHARMA INC | $7.5M | 290.6K | 0.76% | — |
| 33 | E EUPRAXIA PHARMACEUTICALS INC | $7.4M | 809.7K | 0.74% | — |
| 34 | T TECTONIC THERAPEUTIC INC | $7.1M | 306.3K | 0.72% | — |
| 35 | A ACADIA PHARMACEUTICALS INC | $7.1M | 350.0K | 0.71% | — |
| 36 | O ORIC PHARMACEUTICALS INC | $7M | 522.8K | 0.71% | — |
| 37 | M MONOPAR THERAPEUTICS INC | $6.9M | 86.8K | 0.70% | — |
| 38 | Q UNIQURE NV | $6.5M | 267.0K | 0.65% | — |
| 39 | B C4 THERAPEUTICS INC | $6.4M | 1.93M | 0.65% | — |
| 40 | A ALPHA COGNITION INC | $6.3M | 701.3K | 0.63% | — |
| 41 | H CYBIN INC | $6.1M | 500.0K | 0.62% | — |
| 42 | I IMMUNOME INC | $6.1M | 285.0K | 0.62% | — |
| 43 | J JADE BIOSCIENCES INC | $6M | 427.3K | 0.60% | — |
| 44 | H CYBIN INC | $6M | 487.6K | 0.60% | — |
| 45 | F FAETH THERAPEUTICS INC | $5.9M | 199.7K | 0.60% | — |
| 46 | ? N/A DAMORA THERAPEUTICS INC | $5.9M | 275.7K | 0.59% | — |
| 47 | F FREENOME INC | $5.7M | 362.6K | 0.57% | — |
| 48 | P PROQR THRAPEUTICS N V | $5.7M | 3.43M | 0.57% | — |
| 49 | R RAPPORT THERAPEUTICS INC | $5.6M | 166.4K | 0.56% | — |
| 50 | C CARDIOL THERAPEUTICS INC | $5.5M | 3.33M | 0.56% | — |